Locations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series B
founded in
2019
Ensoma is pioneering a new kind of genomic medicine by developing one-time, off-the-shelf, in vivo treatments that durably engineer hematopoietic stem cells to cure diseases from within. Their advanced platform combines a unique delivery system with a gene engineering toolkit, allowing for selective modification of cells in the hematopoietic system. This innovative approach offers unprecedented versatility in treating various diseases, positioning Ensoma as a leader in the next wave of genetic medicine. The company is rapidly advancing its pipeline, targeting genetic, immune, and oncological diseases, and is supported by top-tier investors, indicating strong market traction and potential for significant impact in the healthcare sector.
Something looks off?On-site & Remote